CN110403196A - 一种抗辐射保健品配方 - Google Patents
一种抗辐射保健品配方 Download PDFInfo
- Publication number
- CN110403196A CN110403196A CN201910777976.2A CN201910777976A CN110403196A CN 110403196 A CN110403196 A CN 110403196A CN 201910777976 A CN201910777976 A CN 201910777976A CN 110403196 A CN110403196 A CN 110403196A
- Authority
- CN
- China
- Prior art keywords
- radiation
- parts
- health care
- care product
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003471 anti-radiation Effects 0.000 title claims abstract description 19
- 230000036541 health Effects 0.000 title claims abstract description 16
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 10
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 8
- 239000000463 material Substances 0.000 claims abstract description 7
- 241001377695 Polygonum arenastrum Species 0.000 claims abstract description 6
- 235000006386 Polygonum aviculare Nutrition 0.000 claims abstract description 6
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 5
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 5
- 235000012680 lutein Nutrition 0.000 claims abstract description 5
- 229960005375 lutein Drugs 0.000 claims abstract description 5
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims abstract description 5
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims abstract description 5
- 239000001656 lutein Substances 0.000 claims abstract description 5
- 229960003080 taurine Drugs 0.000 claims abstract description 5
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims abstract description 5
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 5
- 229940046009 vitamin E Drugs 0.000 claims abstract description 5
- 239000011709 vitamin E Substances 0.000 claims abstract description 5
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims abstract description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 4
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims abstract description 4
- 229930014669 anthocyanidin Natural products 0.000 claims abstract description 4
- 150000001452 anthocyanidin derivatives Chemical class 0.000 claims abstract description 4
- 235000008758 anthocyanidins Nutrition 0.000 claims abstract description 4
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 4
- 239000011718 vitamin C Substances 0.000 claims abstract description 4
- 235000011478 zinc gluconate Nutrition 0.000 claims abstract description 4
- 229960000306 zinc gluconate Drugs 0.000 claims abstract description 4
- 239000011670 zinc gluconate Substances 0.000 claims abstract description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 6
- 235000019359 magnesium stearate Nutrition 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- 241000489523 Veratrum Species 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 abstract description 8
- 230000003078 antioxidant effect Effects 0.000 abstract description 8
- 235000006708 antioxidants Nutrition 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 8
- 230000036039 immunity Effects 0.000 abstract description 6
- 150000003254 radicals Chemical class 0.000 abstract description 5
- 210000004556 brain Anatomy 0.000 abstract description 4
- 230000009758 senescence Effects 0.000 abstract description 4
- 239000000049 pigment Substances 0.000 abstract description 3
- 210000001525 retina Anatomy 0.000 abstract description 3
- 230000036559 skin health Effects 0.000 abstract description 3
- 230000003111 delayed effect Effects 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 abstract description 2
- 230000005855 radiation Effects 0.000 description 14
- 230000005670 electromagnetic radiation Effects 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 2
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical group C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 206010048259 Zinc deficiency Diseases 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 210000001320 hippocampus Anatomy 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 208000032839 leukemia Diseases 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000021283 resveratrol Nutrition 0.000 description 2
- 229940016667 resveratrol Drugs 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010018275 Gingival atrophy Diseases 0.000 description 1
- 206010018276 Gingival bleeding Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010021929 Infertility male Diseases 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 208000007466 Male Infertility Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 239000004285 Potassium sulphite Substances 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002019 anti-mutation Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000009702 cancer cell proliferation Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 239000008845 cholagoga Substances 0.000 description 1
- 229940124571 cholagogue Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 201000005562 gingival recession Diseases 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 208000011759 gum bleeding Diseases 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000005965 immune activity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000017708 myomatous neoplasm Diseases 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- LUKBXSAWLPMMSZ-UHFFFAOYSA-N resveratrol Chemical compound C1=CC(O)=CC=C1C=CC1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-UHFFFAOYSA-N 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000036301 sexual development Effects 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 230000008010 sperm capacitation Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000005062 synaptic transmission Effects 0.000 description 1
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明涉及一种抗辐射保健品配方，由如下重量份的原料制成：虎杖提取物225份、叶黄素22.5份、花青素22.5份、牛磺酸15份、维生素C0.3份、维生素E0.3份、葡萄糖酸锌14.1份、辅料0.3份。本发明的抗辐射保健品配方含有多种抗辐射成分，能够起到抗氧化，抗辐射，清除自由基，延缓衰老，保护皮肤健康，消徐皮肤粗糙及色素色斑，巩固细组织，保护大脑，保护视网膜増加心脏收缩能力，提高免疫力等诸多功效。
Description
技术领域
本发明涉及保健品领域，特别涉及一种抗辐射保健品配方。
背景技术
辐射指的是能量以波或是次原子粒子移动的型态传送。辐射之能量从辐射源向外所有方向直线放射。一般可依其能量的高低及电离物质的能力分类为电离辐射或非电离辐射。一般普遍将这个名词用在电离辐射。联合国人类环境大会将电磁辐射列入必须控制的主要污染物之一。电磁辐射既包括电器设备如电视塔、手机、电磁波发射塔等运行时产生的高强度电磁波，也包括计算机、变电站、电视机、微波炉等家用电器使用时产生的电磁辐射。这些电磁辐射充斥空间，无色无味无形，可以穿透包括人体在内的多种物质。人体如果长期暴露在超过安全的辐射剂量下，细胞就会被大面积杀伤或杀死。据国外资料显示，电磁辐射已成为当今危害人类健康的致病源之一。电磁波磁场中，人群白血病发病为正常环境中的2.93倍，肌肉肿瘤发病为正常环境中的3.26倍。国内外多数专家认为，电磁辐射是造成儿童白血病的原因之一，并能诱发人体癌细胞增殖，影响人的生殖系统，导致儿童智力残缺，影响人的心血管系统，且对人们的视觉系统有不良影响。不过专家们同时指出，对辐射也不必过于恐惧，因为辐射不属于强致癌因素，不会引起“特殊癌”，只是使癌的发生率有所提高。据对现有资料统计分析，只有4%的肿瘤是电离辐射造成的。而且辐射危害是可以预防的，辐射造成的损伤也是可以治疗的。
随着我国经济的飞速发展，国民生活水平的提高，电子产品日趋多样化，而其发出的辐射对人体的伤害不容小觑。为了自身的健康，积极地学习怎样科学地安全地抗辐射是很有必要的。
发明内容
本发明公开了一种抗辐射保健品配方，由如下重量份的原料制成：虎杖提取物225份、叶黄素22.5份、花青素22.5份、牛磺酸15份、维生素C0.3份、维生素E0.3份、葡萄糖酸锌14.1份、辅料0.3份。
在其中一个实施例中，所述虎杖提取物为白藜芦醇。
在其中一个实施例中，所述辅料为硬脂酸镁。
本发明各种成分的有益效果：
白藜芦醇：抗癌抗突变；保护心血管，防治高血脂、动脉硬化、心脏和肝脏损伤；抗血栓形成；提升免疫系统活性；抗氧化和清除自由基、抗菌消炎镇痛和减肥降脂的功效。
叶黄素：抗电脑和手机对眼睛的辐射，保护视网膜；强抗氧化剂，有效清除体内多余的自由基，美容养颜，增强免疫力，延缓衰老；抑制癌症及心脏病危险。
原花青素：高效抗氧化和软化血管、増强血管弹性和血流量，其抗氧化力是维生素E的50倍，维生素C的20倍，有抗过敏、抗癌、抗衰老的作用。
牛磺酸：解热、镇痛、保肝、降血糖，维护正常视觉功能，调节神经传导，调节脂类代谢，利胆护肝，参与内分泌活动，増加心脏收缩能力，提高免疫力。
维生素C：促进骨胶原的生物合成,促进加快创伤组织愈合;促进氨基酸中酪氨酸的代谢,延长肌体寿命;改善铁、钙、锌和叶酸的吸收与利用，有助于改善营养性贫血；増强肌体对外界环境尤其是电脑和手机辐射的抗应激能力和免疫力，有很强的抗辐射、抗氧化、清除自由基能力；改善脂肪和类脂特别是胆固醇的代谢，软化血管，增加血流量，预防心血管疾病；促进牙齿和骨骼生长，防止牙床出血和牙龈萎缩，巩固细组织，保护大脑。
维生素E：抗氧化，抗辐射，清除自由基，延缓衰老，保持红细胞的完整性，改善微循环，参与DNA的合成。
锌：参与人体内200多种酶的组成，维持人体生命活动；促进机体的生长发育和组织再生。增强记忆力。促进脑蛋白RA、DA的合成分解，影响神经传递水平和海马体功能的发挥，而海马体与学习和记忆力密切相关；增强免疫力，对免疫功能具有营养和调节作用。增强胸腺、脾脏、淋巴的免疫功能，增强胸腺激素的含量，提高T细胞杀伤活力；参与VitA的代谢活动和维持正常视觉力，减少VitC排泄量，协同VitE发挥功能；对人体的性发育、性功能、生殖细胞的生成起重要作用，故有“生命的火花”与“婚姻和谐素”之称。维持男性正常的生精功能，锌元素大量存在于男性睾丸中，参与精子的整个生成、成熟和获能的过程。男性一旦缺锌，就会导致精子数量减少，活力下降，精液液化不良，最终导致男性不育，缺锌还会导致青少年沒有第二性征出现，不能正常生殖发育；维持人体正常食欲；促进伤口和创伤愈合，保护皮肤健康，消徐皮肤粗糙及色素色斑，抗氧化、抗辐射。
本发明的抗辐射保健品配方含有多种抗辐射成分，能够起到抗氧化，抗辐射，清除自由基，延缓衰老，保护皮肤健康，消徐皮肤粗糙及色素色斑，巩固细组织，保护大脑，保护视网膜増加心脏收缩能力，提高免疫力等诸多功效。
具体实施方式
下面将对本发明实施例中的技术方案进行清楚、完整地描述，显然，所描述的实施例仅是本发明的一部分实施例，而不是全部的实施例。基于本发明中的实施例，本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其它实施例，都属于本发明保护的范围。
本发明实施例公开了一种抗辐射保健品配方，其可制作净重300mg的片剂保健品，每片该保健品中各原料的含量为：
虎杖提取物（白藜芦醇）225毫克、叶黄素22.5毫克、花青素22.5毫克、牛磺酸15毫克、维生素C0.3毫克、维生素E0.3毫克、葡萄糖酸锌14.1毫克、辅料（硬脂酸镁）0.3毫克。
本发明所述的实施例仅仅是对本发明的优选实施方式进行的描述，并非对本发明构思和范围进行限定，在不脱离本发明设计思想的前提下，本领域中工程技术人员对本发明的技术方案作出的各种变型和改进，均应落入本发明的保护范围，本发明请求保护的技术内容，已经全部记载在权利要求书中。
Claims (3)
1.一种抗辐射保健品配方，其特征在于，由如下重量份的原料制成：虎杖提取物225份、叶黄素22.5份、花青素22.5份、牛磺酸15份、维生素C0.3份、维生素E0.3份、葡萄糖酸锌14.1份、辅料0.3份。
2.根据权利要求1所述的抗辐射保健品配方，其特征在于：所述虎杖提取物为白藜芦醇。
3.根据权利要求1所述的抗辐射保健品配方，其特征在于：所述辅料为硬脂酸镁。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910777976.2A CN110403196A (zh) | 2019-08-22 | 2019-08-22 | 一种抗辐射保健品配方 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910777976.2A CN110403196A (zh) | 2019-08-22 | 2019-08-22 | 一种抗辐射保健品配方 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110403196A true CN110403196A (zh) | 2019-11-05 |
Family
ID=68368440
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910777976.2A Pending CN110403196A (zh) | 2019-08-22 | 2019-08-22 | 一种抗辐射保健品配方 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110403196A (zh) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101416742A (zh) * | 2008-11-07 | 2009-04-29 | 广州蓝钥匙海洋生物工程有限公司 | 一种用于对辐射危害有辅助保护作用的保健食品 |
| CN103564584A (zh) * | 2013-10-22 | 2014-02-12 | 刘春华 | 抗辐射护眼饮品 |
| CN108354180A (zh) * | 2018-05-24 | 2018-08-03 | 江西人之初营养科技股份有限公司 | 一种有助于缓解蓝光辐射伤害的组合物及其应用 |
| CN108939040A (zh) * | 2018-10-18 | 2018-12-07 | 云南德彩堂生物医药科技有限公司 | 一种抗辐射组合物及其制备方法和应用 |
-
2019
- 2019-08-22 CN CN201910777976.2A patent/CN110403196A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101416742A (zh) * | 2008-11-07 | 2009-04-29 | 广州蓝钥匙海洋生物工程有限公司 | 一种用于对辐射危害有辅助保护作用的保健食品 |
| CN103564584A (zh) * | 2013-10-22 | 2014-02-12 | 刘春华 | 抗辐射护眼饮品 |
| CN108354180A (zh) * | 2018-05-24 | 2018-08-03 | 江西人之初营养科技股份有限公司 | 一种有助于缓解蓝光辐射伤害的组合物及其应用 |
| CN108939040A (zh) * | 2018-10-18 | 2018-12-07 | 云南德彩堂生物医药科技有限公司 | 一种抗辐射组合物及其制备方法和应用 |
Non-Patent Citations (3)
| Title |
|---|
| 李斌等: "白藜芦醇对辐射损伤后小鼠肠粘膜免疫屏障的保护作用", 《贵州大学学报(自然科学版)》 * |
| 李程程等: "白藜芦醇对小鼠辐射氧化损伤的保护性研究", 《陕西医学杂志》 * |
| 马征等: "白藜芦醇对辐射损伤的保护作用", 《中南大学学报(医学版)》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111990558A (zh) | 一种吸收效果好的美白抗氧化复合果饮及其制备方法 | |
| CN110522038A (zh) | 复合蓝莓、黑果腺肋花楸和鱼胶原蛋白肽的健康食品 | |
| CN102309007B (zh) | 一种营养补充剂及其制备方法 | |
| CN102362846A (zh) | 一种皮肤防辐射组合物 | |
| KR20200017699A (ko) | 식물 복합추출물의 유효성분을 포함하는 피부 주름개선용 노란색 화장료 조성물 | |
| CN105310933A (zh) | 一种抗衰老美容面膜有效成分的配方 | |
| CN106620639A (zh) | 一种补充眼营养抗皱的叶黄素复方植物眼贴 | |
| CN110403196A (zh) | 一种抗辐射保健品配方 | |
| CN103564584A (zh) | 抗辐射护眼饮品 | |
| CN107518398A (zh) | 一种保护和改善男性前列腺功能的营养素 | |
| ZA202306644B (en) | Application of chinese liquor in the preparation of medicines for improving intestinal barrier functions and gut microbiota | |
| CN103766916A (zh) | 一种女性保健品及其制备方法 | |
| CN112472623A (zh) | 一种具有美白和修护功效的精华液及其制备方法和应用 | |
| CN103040662A (zh) | 一种抗老化眼霜 | |
| CN110236987A (zh) | 一种软枣猕猴桃颈膜 | |
| Du et al. | The physiological function of squalene and its application prospects in animal husbandry | |
| CN104546632A (zh) | 一种丝瓜祛斑美白护肤品 | |
| TW201350134A (zh) | 美白、淡斑的組成物 | |
| CN102343000A (zh) | 具有凉血止痢功效畜禽用中药组合物及其制备方法 | |
| CN101966263A (zh) | Ｓｏｄ抗氧化保健品 | |
| CN105213274A (zh) | 天然植物营养素和细胞生长修复因子的近自然护肤品 | |
| KR20030022500A (ko) | 피부 미백용 건강식품 조성물 | |
| CN104784378B (zh) | 一种治疗原发性三叉神经痛的药剂 | |
| TW201350133A (zh) | 防老和美白的組成物 | |
| CN1192719C (zh) | 防治电子污染的保健食品 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191105 |
|
| RJ01 | Rejection of invention patent application after publication |